BR9813753A - "processo para complexo ifnar2/ifn" - Google Patents
"processo para complexo ifnar2/ifn"Info
- Publication number
- BR9813753A BR9813753A BR9813753-0A BR9813753A BR9813753A BR 9813753 A BR9813753 A BR 9813753A BR 9813753 A BR9813753 A BR 9813753A BR 9813753 A BR9813753 A BR 9813753A
- Authority
- BR
- Brazil
- Prior art keywords
- ifn
- complex
- ifnar
- interferon
- peptide
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 102000014150 Interferons Human genes 0.000 abstract 11
- 108010050904 Interferons Proteins 0.000 abstract 11
- 229940079322 interferon Drugs 0.000 abstract 11
- 101000852870 Homo sapiens Interferon alpha/beta receptor 1 Proteins 0.000 abstract 3
- 102100036714 Interferon alpha/beta receptor 1 Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 108020001507 fusion proteins Proteins 0.000 abstract 2
- 102000037865 fusion proteins Human genes 0.000 abstract 2
- 101000852865 Homo sapiens Interferon alpha/beta receptor 2 Proteins 0.000 abstract 1
- 102000002227 Interferon Type I Human genes 0.000 abstract 1
- 108010014726 Interferon Type I Proteins 0.000 abstract 1
- 102100036718 Interferon alpha/beta receptor 2 Human genes 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Patente de Invenção: <B>"PROCESSO PARA COMPLEXO IFNAR2/IFN"<D>. O efeito in vivo da interferona do Tipo I (IFN) pode ser prolongado pela administração da interferona na forma de um complexo com uma cadeia vinculadora de IFN do receptor <244>/ß de interferona humana (IFNAR). Este complexo também melhora a estabilidade da IFN e amplia a potência da IFN. O complexo pode ser um complexo não-covalente ou um em que a IFN e a IFNAR seja ligadas por um elo covalente ou um peptídio. Quando ligada por um elo peptídio na forma de uma proteína de fusão, a IFN pode ser separada da IFNAR por meio de um vinculador peptídio. Esta proteína de fusão pode ser produzida por tecnologia de DNA recombinante. O armazenamento da IFN na forma deste complexo melhora a vida de armazenamento da IFN e permite o estocamento sob condições mais suaves do que seria de outra forma possível.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6829597P | 1997-12-19 | 1997-12-19 | |
| PCT/US1998/026926 WO1999032141A1 (en) | 1997-12-19 | 1998-12-18 | Ifnar2/ifn complex |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9813753A true BR9813753A (pt) | 2000-10-10 |
Family
ID=22081665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9813753-0A BR9813753A (pt) | 1997-12-19 | 1998-12-18 | "processo para complexo ifnar2/ifn" |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6372207B1 (pt) |
| EP (1) | EP1037658B1 (pt) |
| JP (1) | JP4601163B2 (pt) |
| KR (1) | KR100593981B1 (pt) |
| CN (1) | CN1241638C (pt) |
| AR (1) | AR020315A1 (pt) |
| AT (1) | ATE218362T1 (pt) |
| AU (1) | AU755078B2 (pt) |
| BG (1) | BG64920B1 (pt) |
| BR (1) | BR9813753A (pt) |
| CA (1) | CA2311648C (pt) |
| DE (1) | DE69805844T2 (pt) |
| DK (1) | DK1037658T3 (pt) |
| EA (1) | EA003635B1 (pt) |
| EE (1) | EE200000355A (pt) |
| ES (1) | ES2174530T3 (pt) |
| HK (1) | HK1032914A1 (pt) |
| HU (1) | HUP0100456A3 (pt) |
| IL (2) | IL136855A0 (pt) |
| NO (1) | NO20002691L (pt) |
| NZ (1) | NZ504771A (pt) |
| PL (1) | PL197568B1 (pt) |
| PT (1) | PT1037658E (pt) |
| SK (1) | SK9222000A3 (pt) |
| TR (1) | TR200001961T2 (pt) |
| UA (1) | UA74132C2 (pt) |
| WO (1) | WO1999032141A1 (pt) |
| ZA (1) | ZA9811634B (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL122818A0 (en) * | 1997-07-10 | 1998-08-16 | Yeda Res & Dev | Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof |
| AUPP670698A0 (en) * | 1998-10-23 | 1998-11-19 | Monash University | A method of regulation |
| US7138379B2 (en) * | 2000-07-26 | 2006-11-21 | Schering Aktiengesellschaft | Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons |
| IL147414A0 (en) | 2001-12-31 | 2002-08-14 | Yeda Res & Dev | Ifnar2 mutants, their production and use |
| US20040175359A1 (en) * | 2002-11-12 | 2004-09-09 | Desjarlais John Rudolph | Novel proteins with antiviral, antineoplastic, and/or immunomodulatory activity |
| EP1666496B1 (en) * | 2003-08-25 | 2014-03-12 | Toray Industries, Inc. | Interferon-beta composite |
| CN100400664C (zh) * | 2005-09-06 | 2008-07-09 | 中国人民解放军第四军医大学 | 肿瘤血管导向肽与人干扰素α-2b的融合蛋白的制备方法 |
| WO2008130382A2 (en) | 2006-10-31 | 2008-10-30 | East Carolina University | Fusion proteins comprising an anti -inflammatory cytokine and an antigen for treatment of immune disorders |
| GB0715383D0 (en) * | 2007-08-08 | 2007-09-19 | Asterion Ltd | Interferon |
| GB0815216D0 (en) * | 2008-08-21 | 2008-09-24 | Asterion Ltd | Interleukin |
| WO2010117848A1 (en) | 2009-03-31 | 2010-10-14 | East Carolina University | Cytokines and neuroantigens for treatment of immune disorders |
| KR101293363B1 (ko) * | 2011-02-28 | 2013-08-05 | 성균관대학교산학협력단 | 인터페론 수용체 유전자를 포함하는 조류독감 예방용 조성물 |
| JP6466904B2 (ja) * | 2013-03-15 | 2019-02-06 | ヤンセン バイオテツク，インコーポレーテツド | インターフェロンアルファ及びオメガ抗体アンタゴニスト |
| LT6164B (lt) | 2013-10-15 | 2015-06-25 | Uab Biotechnologinės Farmacijos Centras "Biotechpharma" | Sulieti interferono-alfa 5 baltymai su kitu citokinu ir jų gamybos būdas |
| EP3641829A4 (en) * | 2017-06-20 | 2021-04-21 | The Board of Regents of The University of Texas System | INTERFERON PRODRUG FOR TREATMENT OF CANCER |
| WO2019040674A1 (en) | 2017-08-22 | 2019-02-28 | Sanabio, Llc | SOLUBLE INTERFERON RECEPTORS AND USES THEREOF |
| CN112646783B (zh) * | 2020-12-30 | 2023-12-01 | 广州医科大学附属市八医院 | 表达基因、经基因修饰的受精卵的构建方法和小鼠模型的构建方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5821078A (en) * | 1992-09-03 | 1998-10-13 | Yeda Research And Development Co. Ltd. | Nucleic acid encoding interferon-α/β binding protein |
| IL106591A (en) | 1992-09-03 | 2008-03-20 | Yeda Res & Dev | Interferon alpha/beta binding protein, its preparation and pharmaceutical compositions containing it |
| IL107378A (en) | 1993-10-24 | 2005-05-17 | Yeda Res & Dev | SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE |
-
1998
- 1998-12-18 DE DE69805844T patent/DE69805844T2/de not_active Expired - Lifetime
- 1998-12-18 US US09/215,212 patent/US6372207B1/en not_active Expired - Lifetime
- 1998-12-18 AR ARP980106515A patent/AR020315A1/es active IP Right Grant
- 1998-12-18 UA UA2000074350A patent/UA74132C2/uk unknown
- 1998-12-18 CA CA2311648A patent/CA2311648C/en not_active Expired - Fee Related
- 1998-12-18 EE EEP200000355A patent/EE200000355A/xx unknown
- 1998-12-18 AU AU19269/99A patent/AU755078B2/en not_active Ceased
- 1998-12-18 IL IL13685598A patent/IL136855A0/xx active IP Right Grant
- 1998-12-18 EA EA200000685A patent/EA003635B1/ru not_active IP Right Cessation
- 1998-12-18 ES ES98964071T patent/ES2174530T3/es not_active Expired - Lifetime
- 1998-12-18 AT AT98964071T patent/ATE218362T1/de not_active IP Right Cessation
- 1998-12-18 SK SK922-2000A patent/SK9222000A3/sk unknown
- 1998-12-18 CN CNB988123924A patent/CN1241638C/zh not_active Expired - Fee Related
- 1998-12-18 NZ NZ504771A patent/NZ504771A/xx unknown
- 1998-12-18 WO PCT/US1998/026926 patent/WO1999032141A1/en active IP Right Grant
- 1998-12-18 PL PL341423A patent/PL197568B1/pl not_active IP Right Cessation
- 1998-12-18 EP EP98964071A patent/EP1037658B1/en not_active Expired - Lifetime
- 1998-12-18 KR KR1020007006160A patent/KR100593981B1/ko not_active IP Right Cessation
- 1998-12-18 HU HU0100456A patent/HUP0100456A3/hu unknown
- 1998-12-18 BR BR9813753-0A patent/BR9813753A/pt not_active Application Discontinuation
- 1998-12-18 DK DK98964071T patent/DK1037658T3/da active
- 1998-12-18 JP JP2000525131A patent/JP4601163B2/ja not_active Expired - Fee Related
- 1998-12-18 ZA ZA9811634A patent/ZA9811634B/xx unknown
- 1998-12-18 PT PT98964071T patent/PT1037658E/pt unknown
- 1998-12-18 TR TR2000/01961T patent/TR200001961T2/xx unknown
-
2000
- 2000-05-25 NO NO20002691A patent/NO20002691L/no not_active Application Discontinuation
- 2000-06-15 BG BG104539A patent/BG64920B1/bg unknown
- 2000-06-18 IL IL136855A patent/IL136855A/en not_active IP Right Cessation
-
2001
- 2001-05-23 HK HK01103574A patent/HK1032914A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9813753A (pt) | "processo para complexo ifnar2/ifn" | |
| ATE327254T1 (de) | Interferon-beta fusionsproteine und deren verwendungen | |
| CY1113145T1 (el) | Μορια υποδοχεα θυμικης στρωματικης λεμφοποιητινης και χρησεις αυτων | |
| DK0643767T3 (da) | Osteogene peptider | |
| CY1114265T1 (el) | Πρωτεϊνη συντηξης αλβουμινης | |
| BR0007035A (pt) | Métodos de controle de pragas de agrótis | |
| BR9910023A (pt) | Conjugados de poliol-ifn-beta | |
| CY1109759T1 (el) | Παραγωγη ανασυνδυασμενης πρωτεϊνης σε ανθρωπινο κυτταρο η οποια περιλαμβανει τουλαχιστον μια ε1 πρωτεϊνη του αδενοϊου | |
| BR9907228A (pt) | Uso de uma proteìna de choque térmico, processo para proteger um mamìfero de uma doença, formulação para proteger um mamìfero de desenvolver uma doença, uso de uma molécula de ácido nucleico, e processo para prescrever um tratamento para hiper-sensibilidade das vias aéreas ou limitação do fluxo de ar associado com uma doença envolvendo resposta inflamatória | |
| DE50112802D1 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
| BR9810478A (pt) | Análogos de hormÈnio glicoproteìna reticulados por dissulfeto e sua preparação e utilização | |
| BR9508467A (pt) | Composição de matéria peptídeo de ligação de receptor de somatostatina composição farmacéutica e processo para realizar uma cirurgia guiada por radiosótopos ou um procedimento de radiodiagnóstico ou radioterapéutico e para aliviar uma doença relacionada com somatostetina em um animal | |
| BR9811592A (pt) | Oxidase de citocinina | |
| DE69505804D1 (de) | Afamin: ein menschliches serum albumin ähnliches protein | |
| BR0009472A (pt) | Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas | |
| DE68925275D1 (de) | Endotoxin-bindeprotein und dessen verwendung | |
| DE60037978D1 (de) | Interferon ähnliche moleküle, und deren verwendungen | |
| BR9808376A (pt) | Moléculas bi- ou multifuncionais com base em uma armação de dendroaspina | |
| CY1109946T1 (el) | Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων | |
| BR9812138A (pt) | Métodos e composições para terapias empregando genes codificando proteìnas segregadas tal como interferon-beta | |
| BR9714376A (pt) | Antagonistas de somatostatina | |
| ATE346919T1 (de) | Nebenhoden-spezifisches rezeptorprotein und dessen verwendung | |
| BR9811907A (pt) | Proteìna de ligação de lactoferrina de neisseria | |
| ATE315646T1 (de) | Leukocyten-aktivierender faktor | |
| WO2002085305A3 (en) | Compositions and methods for inducing cancer cell death |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 37, SUGIRO O INDEFERIMENTO DO PRESENTE PEDIDO, TENDO POR BASE O ARTIGO 8O COMBINADO COM O ARTIGO 13, E ARTIGOS 18(III), 24 E 25 DA LPI 9279 DE 14/05/96. |